Johnson & Johnson (JNJ) Stake Boosted by Portland Global Advisors LLC

Portland Global Advisors LLC increased its stake in Johnson & Johnson (NYSE:JNJ) by 2.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,714 shares of the company’s stock after buying an additional 196 shares during the period. Portland Global Advisors LLC’s holdings in Johnson & Johnson were worth $1,210,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the company. Lenox Wealth Advisors Inc. increased its position in Johnson & Johnson by 0.7% in the first quarter. Lenox Wealth Advisors Inc. now owns 871 shares of the company’s stock valued at $108,000 after buying an additional 6 shares during the last quarter. Thomas J. Herzfeld Advisors Inc. acquired a new position in Johnson & Johnson during the fourth quarter valued at $117,000. Empirical Finance LLC acquired a new position in Johnson & Johnson during the fourth quarter valued at $144,000. Foundation Resource Management Inc. acquired a new position in Johnson & Johnson during the first quarter valued at $204,000. Finally, Merriman Wealth Management LLC purchased a new position in shares of Johnson & Johnson during the first quarter valued at approximately $218,000. 66.07% of the stock is currently owned by institutional investors and hedge funds.

Johnson & Johnson (NYSE:JNJ) traded up 0.78% during trading on Friday, reaching $131.85. 4,970,860 shares of the company’s stock traded hands. Johnson & Johnson has a one year low of $109.32 and a one year high of $137.08. The firm has a market cap of $355.18 billion, a price-to-earnings ratio of 22.31 and a beta of 0.78. The company has a 50 day moving average of $133.27 and a 200 day moving average of $125.08.

Johnson & Johnson (NYSE:JNJ) last announced its earnings results on Tuesday, July 18th. The company reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.79 by $0.04. The company had revenue of $18.84 billion for the quarter, compared to the consensus estimate of $18.94 billion. Johnson & Johnson had a return on equity of 26.83% and a net margin of 22.52%. The company’s revenue was up 1.9% on a year-over-year basis. During the same period last year, the business posted $1.74 EPS. Equities research analysts predict that Johnson & Johnson will post $7.18 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Tuesday, August 29th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Friday, August 25th. This represents a $3.36 annualized dividend and a dividend yield of 2.55%. Johnson & Johnson’s dividend payout ratio is currently 56.76%.

WARNING: “Johnson & Johnson (JNJ) Stake Boosted by Portland Global Advisors LLC” was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this piece on another site, it was copied illegally and republished in violation of US & international copyright & trademark law. The correct version of this piece can be accessed at https://www.chaffeybreeze.com/2017/07/29/johnson-johnson-jnj-shares-bought-by-portland-global-advisors-llc-updated-updated-updated.html.

A number of equities analysts have commented on JNJ shares. BTIG Research cut shares of Johnson & Johnson from a “neutral” rating to a “sell” rating and set a $110.00 price target for the company. in a research note on Friday, July 21st. Atlantic Securities cut shares of Johnson & Johnson from a “neutral” rating to an “underweight” rating and set a $113.00 price target for the company. in a research note on Friday, July 21st. Alembic Global Advisors lowered shares of Johnson & Johnson from a “neutral” rating to an “underweight” rating in a report on Friday, July 21st. Zacks Investment Research lowered shares of Johnson & Johnson from a “buy” rating to a “hold” rating in a report on Friday, July 21st. Finally, Credit Suisse Group started coverage on shares of Johnson & Johnson in a report on Thursday, July 20th. They issued an “outperform” rating and a $148.00 price objective for the company. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $133.72.

In related news, VP Paulus Stoffels sold 102,692 shares of Johnson & Johnson stock in a transaction on Monday, July 24th. The stock was sold at an average price of $133.14, for a total transaction of $13,672,412.88. Following the completion of the transaction, the vice president now directly owns 230,342 shares of the company’s stock, valued at $30,667,733.88. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Dominic J. Caruso sold 82,591 shares of Johnson & Johnson stock in a transaction on Thursday, July 20th. The stock was sold at an average price of $136.72, for a total value of $11,291,841.52. Following the transaction, the vice president now directly owns 226,693 shares of the company’s stock, valued at $30,993,466.96. The disclosure for this sale can be found here. 0.19% of the stock is owned by company insiders.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply